Lotus Eye Hospital And Institute Ltd

Lotus Eye Hospital And Institute Ltd

$LOTUSEYEHospitalNSEBSE

Lotus Eye Hospital And Institute Ltd (LOTUSEYE) last traded at ₹113, a market capitalisation of ₹235 crore, on a P/E of 1469. Over the past 52 weeks the stock has ranged between ₹97.6 and ₹153. Lotus Eye Hospital And Institute Ltd last reported results for the quarter ended Jun 2026, with sales of ₹17.06 crore and net profit of ₹0.61 crore. Figures are as of 25 Aug 2026 and are not real time.

Lotus Eye Hospital And Institute Ltd share price and key metrics

Current price
₹113
Market cap
₹235 cr
Stock P/E
1469
Book value
₹28.9
ROE
0.13%
ROCE
1.16%
Dividend yield
0.00%
52w high / low
153/97.6

Metrics as of 25 Aug 2026. Not real time.

Lotus Eye Hospital And Institute Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹17.06 cr, up 26.2% from ₹13.52 cr a year earlier. Net profit was ₹0.61 cr, up 13.0% year on year.

Lotus Eye Hospital And Institute Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales12.9112.2511.5113.5213.0413.5513.6117.06
Expenses11.7611.4611.6812.0412.2712.8913.1314.11
Operating profit1.150.79-0.171.480.770.660.482.95
OPM %8.91%6.45%-1.48%10.95%5.90%4.87%3.53%17.29%
Other income0.270.220.520.190.270.240.470.21
Interest0.080.130.090.120.120.290.330.51
Depreciation1.231.31-0.580.820.850.981.11.64
Profit before tax0.11-0.430.840.730.07-0.37-0.481.01
Tax %9.09%-44.19%70.24%24.66%-71.43%-29.73%-33.33%39.60%
Net profit0.1-0.240.250.540.12-0.26-0.320.61
EPS (₹)0.05-0.120.120.260.06-0.13-0.150.29

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Lotus Eye Hospital And Institute Ltd annual results

Lotus Eye Hospital And Institute Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales32.3538.947.0348.249.5553.7157.26
Operating profit3.625.927.686.633.563.384.86
OPM %11.19%15.22%16.33%13.76%7.18%6.29%8.49%
Net profit1.572.984.082.910.740.080.15
EPS (₹)0.751.431.961.400.360.040.07

TTM is the trailing twelve months to the most recent quarter.

Lotus Eye Hospital And Institute Ltd growth and returns

Compounded Sales Growth
10 Years
6%
5 Years
11%
3 Years
5%
TTM
14%
Compounded Profit Growth
10 Years
-1%
5 Years
-44%
3 Years
-73%
TTM
-75%
Stock Price CAGR
10 Years
22%
5 Years
22%
3 Years
11%
1 Year
13%
Return on Equity
10 Years
3%
5 Years
4%
3 Years
2%
Last Year
0%

Lotus Eye Hospital And Institute Ltd shareholding pattern

Promoters held 40.14% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.00% and DIIs 0.02%.

Lotus Eye Hospital And Institute Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters40.03%40.14%40.22%40.39%40.63%40.66%40.14%40.14%
FIIs0.00%0.00%0.00%0.01%0.00%0.01%0.00%0.00%
DIIs0.00%0.04%0.04%0.02%0.02%0.02%0.02%0.02%
Public59.97%59.82%59.73%59.57%59.33%59.31%59.85%59.85%
No. of shareholders12,51411,73411,50811,12110,77710,2409,9399,627

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Lotus Eye Hospital And Institute Ltd corporate filings

  • Newspaper Advertisements published for Standalone Unaudited Financial Results for the quarter ended June 30, 2026Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Lotus Eye Hospital and Institute Limited reported a strong performance for the quarter…

    Read the full analysis
  • Approved Standalone Unaudited Financial Results for the quarter ended June 30, 2026.Board Meetinghigh impact
    Filing PDF

    Cruxal's analysis: Lotus Eye Hospital and Institute Limited reported a robust performance for the quarter…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Lotus Eye Hospital And Institute Ltd

Cruxal reads every Lotus Eye Hospital And Institute Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Lotus Eye Hospital And Institute Ltd (LOTUSEYE) Results, Financials & Share Price | Cruxal